{"PubmedBookArticle": [], "PubmedArticle": [{"MedlineCitation": {"KeywordList": [["Calotropis procera", "Danio rerio", "Glioblastoma multiforme", "Histone deacetylases", "Human angiogenesis antibody array"]], "OtherAbstract": [], "SpaceFlightMission": [], "InvestigatorList": [], "CitationSubset": [], "OtherID": [], "GeneralNote": [], "PMID": "38304784", "DateRevised": {"Year": "2024", "Month": "02", "Day": "03"}, "Article": {"Language": ["eng"], "ELocationID": ["e24406", "10.1016/j.heliyon.2024.e24406"], "ArticleDate": [{"Year": "2024", "Month": "01", "Day": "12"}], "Journal": {"ISSN": "2405-8440", "JournalIssue": {"Volume": "10", "Issue": "2", "PubDate": {"Year": "2024", "Month": "Jan", "Day": "30"}}, "Title": "Heliyon", "ISOAbbreviation": "Heliyon"}, "ArticleTitle": "<i>Calotropis procera:</i> A double edged sword against glioblastoma, inhibiting glioblastoma cell line growth by targeting histone deacetylases (HDAC) and angiogenesis.", "Pagination": {"StartPage": "e24406", "MedlinePgn": "e24406"}, "Abstract": {"AbstractText": ["Despite substantial investments in anti-glioblastoma (GBM) drug discovery over the last decade, progress is limited to preclinical stages, with clinical studies frequently encountering obstacles. Angiogenic and histone deacetylase inhibitors (HDACi) have shown profound results in pre-clinical studies. Investigating a multicomponent anti-cancer remedy that disrupts the tumor angiogenic blood vessels and simultaneously disrupts HDACs, while inducing minimal side effects, is critically needed. The crude extracts derived from medicinal plants serve as a renewable reservoir of anti-tumor drugs, exhibiting reduced toxicity compared to chemically synthesized formulations. <i>Calotropis procera</i> is a traditional medicinal plant, and its anticancer potential against many cancer cell lines has been reported, however its antiangiogenic and HDAC inhibitory action is largely unknown. The anticancer activity of methanol leaf extract of <i>C. procera</i> was tested in three types of human glioblastoma cell lines. Wild-type and transgenic zebrafish embryos were used to evaluate developmental toxicity and angiogenic activity. A human angiogenic antibody array was used to profile angiogenic proteins in the U251 GM cell line. A real-time reverse transcriptase polymerase chain reaction (RT PCR) assay was used to detect the differential expression of eleven HDAC genes in U251\u00a0cells treated with <i>C. procera</i> extract. The extract significantly reduced the proliferation of all three types of GBM cell lines and the cytotoxicity was found to be more pronounced in U251 GM cells, with an IC<sub>50</sub> value of 2.63\u00a0\u00b1\u00a00.23\u00a0\u03bcg/ml, possibly by arresting the cell cycle at the G2/M transition. The extract did not exhibit toxic effects in zebrafish embryos, even at concentrations as high as 1000\u00a0\u03bcg/ml. The extract also inhibited angiogenic blood vessel formation in the transgenic zebrafish model in a dose-dependent manner. The results from the angiogenic antibody array have suggested novel angiogenesis targets that can be utilized to treat GBM. Real-time RT PCR analysis has shown that <i>C. procrea</i> extract caused an upregulation of HDAC5, 7, and 10, while the mRNA of HDAC1, 2, 3 and 8 (Class I HDACs), and HDAC4, 6, and 9 (Class II) were downregulated in U251 GM cells. The cytotoxicity of the <i>C. procera</i> extract on GBM cell lines could be due to its dual action by regulation of both tumor angiogenesis and histone deacetylases enzymes. Through this study, the <i>C. procera</i> leaf extract has been suggested as an effective remedy to treat GBM with minimal toxicity. In addition, various novel angiogenic and HDAC targets has been identified which could be helpful in designing better therapeutic strategies to manage glioblastoma multiforme in human patients."], "CopyrightInformation": "\u00a9 2024 The Authors."}, "AuthorList": [{"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Bioproducts Research Chair, Department of Zoology, College of Science, King Saud University, P.O Box 2455 Riyadh 11451, Kingdom of Saudi Arabia."}], "LastName": "Saleh Alanazi", "ForeName": "Shamsa Hilal", "Initials": "SH"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Bioproducts Research Chair, Department of Zoology, College of Science, King Saud University, P.O Box 2455 Riyadh 11451, Kingdom of Saudi Arabia."}], "LastName": "Farooq Khan", "ForeName": "Muhammad", "Initials": "M"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Translational Genomics Department, Centre for Genomic Medicine, King Faisal Specialist Hospital & Research Centre, Riyadh, Saudi Arabia."}], "LastName": "Alazami", "ForeName": "Anas M", "Initials": "AM"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Bioproducts Research Chair, Department of Zoology, College of Science, King Saud University, P.O Box 2455 Riyadh 11451, Kingdom of Saudi Arabia."}], "LastName": "Baabbad", "ForeName": "Almohannad", "Initials": "A"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Bioproducts Research Chair, Department of Zoology, College of Science, King Saud University, P.O Box 2455 Riyadh 11451, Kingdom of Saudi Arabia."}], "LastName": "Ahmed Wadaan", "ForeName": "Mohammad", "Initials": "M"}], "PublicationTypeList": ["Journal Article"]}, "MedlineJournalInfo": {"Country": "England", "MedlineTA": "Heliyon", "NlmUniqueID": "101672560", "ISSNLinking": "2405-8440"}, "CoiStatement": "The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper."}, "PubmedData": {"ReferenceList": [{"ReferenceList": [], "Reference": [{"Citation": "Agnihotri S., Burrell K.E., Wolf A., Jalali S., Hawkins C., Rutka J.T., Zadeh G. Glioblastoma, a brief review of history, molecular genetics, animal models and novel therapeutic strategies. Arch. Immunol. Ther. Exp. 2013;61(1):25\u201341.", "ArticleIdList": ["23224339"]}, {"Citation": "Sung H., Ferlay J., Siegel R.L., Laversanne M., Soerjomataram I., Jemal A., Bray F. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. Ca-Cancer J Clin. 2021;71(3):209\u2013249.", "ArticleIdList": ["33538338"]}, {"Citation": "Moin A., Rizvi S.M.D., Hussain T., Gowda D.V., Subaiea G.M., Elsayed M.M.A., Ansari M., Alanazi A.S., Yadav H. Current status of brain tumor in the Kingdom of Saudi Arabia and application of nanobiotechnology for its treatment: a comprehensive review. Life. 2021;11(5)", "ArticleIdList": ["PMC8148129", "34063122"]}, {"Citation": "Ahir B.K., Engelhard H.H., Lakka S.S. Tumor development and angiogenesis in adult brain tumor: glioblastoma. Mol. Neurobiol. 2020;57(5):2461\u20132478.", "ArticleIdList": ["PMC7170819", "32152825"]}, {"Citation": "Hwang H.H., Kim H.S., Lee D.Y. Gastrointestinally absorbable lactoferrin-heparin conjugate with anti-angiogenic activity for treatment of brain tumor. J. Contr. Release. 2023;355:730\u2013744.", "ArticleIdList": ["36764526"]}, {"Citation": "Buccarelli M., Castellani G., Ricci-Vitiani L. Glioblastoma-specific strategies of vascularization: implications in anti-angiogenic therapy resistance. J. Personalized Med. 2022;12(10)", "ArticleIdList": ["PMC9604754", "36294763"]}, {"Citation": "Weller M., van den Bent M., Preusser M., Le Rhun E., Tonn J.C., Minniti G., Bendszus M., Balana C., Chinot O., Dirven L., French P., Hegi M.E., Jakola A.S., Platten M., Roth P., Ruda R., Short S., Smits M., Taphoorn M.J.B., von Deimling A., Westphal M., Soffietti R., Reifenberger G., Wick W. EANO guidelines on the diagnosis and treatment of diffuse gliomas of adulthood. Nat. Rev. Clin. Oncol. 2021;18(3):170\u2013186.", "ArticleIdList": ["PMC7904519", "33293629"]}, {"Citation": "Winkler F., Osswald M., Wick W. Anti-angiogenics: their role in the treatment of glioblastoma. Oncol. Res. Treat. 2018;41(4):181\u2013186.", "ArticleIdList": ["29562225"]}, {"Citation": "Diaz R.J., Ali S., Qadir M.G., De La Fuente M.I., Ivan M.E., Komotar R.J. The role of bevacizumab in the treatment of glioblastoma. J. Neuro Oncol. 2017;133(3):455\u2013467.", "ArticleIdList": ["28527008"]}, {"Citation": "Brandes A.A., Bartolotti M., Tosoni A., Poggi R., Franceschi E. Practical management of bevacizumab-related toxicities in glioblastoma. Oncol. 2015;20(2):166\u2013175.", "ArticleIdList": ["PMC4319633", "25568148"]}, {"Citation": "Yehya A.H.S., Asif M., Tan Y.J., Sasidharan S., Abdul Majid A.M.S., Oon C.E. Broad spectrum targeting of tumor vasculature by medicinal plants: an updated review. J. Herb. Med. 2017;9:1\u201313."}, {"Citation": "Williams M.J., Singleton W.G., Lowis S.P., Malik K., Kurian K.M. Therapeutic targeting of histone modifications in adult and pediatric high-grade glioma. Front. Oncol. 2017;7:45.", "ArticleIdList": ["PMC5368219", "28401060"]}, {"Citation": "Chen R., Zhang M., Zhou Y., Guo W., Yi M., Zhang Z., Ding Y., Wang Y. The application of histone deacetylases inhibitors in glioblastoma. J. Exp. Clin. Cancer Res. 2020;39(1):138.", "ArticleIdList": ["PMC7368699", "32682428"]}, {"Citation": "Lee D.H., Ryu H.W., Won H.R., Kwon S.H. Advances in epigenetic glioblastoma therapy. Oncotarget. 2017;8(11):18577\u201318589.", "ArticleIdList": ["PMC5392350", "28099914"]}, {"Citation": "Marampon F., Leoni F., Mancini A., Pietrantoni I., Codenotti S., Ferella L., Megiorni F., Porro G., Galbiati E., Pozzi P., Mascagni P., Budillon A., Maggio R., Tombolini V., Fanzani A., Gravina G.L., Festuccia C. Histone deacetylase inhibitor ITF2357 (givinostat) reverts transformed phenotype and counteracts stemness in in vitro and in vivo models of human glioblastoma. J. Cancer Res. Clin. Oncol. 2019;145(2):393\u2013409.", "ArticleIdList": ["30474756"]}, {"Citation": "de Ruijter A.J., van Gennip A.H., Caron H.N., Kemp S., van Kuilenburg A.B. Histone deacetylases (HDACs): characterization of the classical HDAC family. Biochem. J. 2003;370(Pt 3):737\u2013749.", "ArticleIdList": ["PMC1223209", "12429021"]}, {"Citation": "Farooq M., Nasr F.A., Almoutiri N.D., Al-yahya N., Wadaan M.A., Abutaha N. The phytochemical screening and antiangiogenic activity of audthan al himar (Moricandia sinaica Boiss.) extracts in zebrafish embryos and human umbilical vein endothelial cells. J. King Saud Univ. Sci. 2020;32(4):2370\u20132376."}, {"Citation": "Gore A.V., Monzo K., Cha Y.R., Pan W., Weinstein B.M. Vascular development in the zebrafish. Cold Spring Harb Perspect Med. 2012;2(5):a006684.", "ArticleIdList": ["PMC3331685", "22553495"]}, {"Citation": "Rajkovic J., Novakovic R., Grujic-Milanovic J., Ydyrys A., Ablaikhanova N., Calina D., Sharifi-Rad J., Al-Omari B. An updated pharmacological insight into calotropin as a potential therapeutic agent in cancer. Front. Pharmacol. 2023;14", "ArticleIdList": ["PMC10149670", "37138852"]}, {"Citation": "Tripathi M., Shukla P.K., Sikarwar R.L.S., Tiwari A.K., Dwivedi N., Tripathi S. Pharmacognostic study of Calotropis procera (Aiton) W.T. Aiton root and stem. Indian J Nat Prod Re. 2022;13(3):374\u2013382."}, {"Citation": "Dogara A.M. A systematic review on the biological evaluation of Calotropis procera (Aiton) Dryand. Futur J Pharm Sci. 2023;9(1)"}, {"Citation": "Pomykala H.M., Bohlander S.K., Broeker P.L., Olopade O.I., Diaz M.O. Breakpoint junctions of chromosome 9p deletions in two human glioma cell lines. Mol. Cell Biol. 1994;14(11):7604\u20137610.", "ArticleIdList": ["PMC359296", "7523863"]}, {"Citation": "Allen M., Bjerke M., Edlund H., Nelander S., Westermark B. Origin of the U87MG glioma cell line: good news and bad news. Sci. Transl. Med. 2016;8(354):354re3.", "ArticleIdList": ["27582061"]}, {"Citation": "Lee Y.-J., Seo H.W., Baek J.-H., Lim S.H., Hwang S.-G., Kim E.H. Gene expression profiling of glioblastoma cell lines depending on TP53 status after tumor-treating fields (TTFields) treatment. Sci Rep-Uk. 2020;10(1)", "ArticleIdList": ["PMC7378235", "32704022"]}, {"Citation": "Torsvik A., Stieber D., Enger P., Golebiewska A., Molven A., Svendsen A., Westermark B., Niclou S.P., Olsen T.K., Chekenya Enger M., Bjerkvig R. U-251 revisited: genetic drift and phenotypic consequences of long-term cultures of glioblastoma cells. Cancer Med. 2014;3(4):812\u2013824.", "ArticleIdList": ["PMC4303149", "24810477"]}, {"Citation": "Aydin H.E., Gunduz M.K., Kizmazoglu C., Kandemir T., Arslantas A. Cytotoxic effect of boron application on glioblastoma cells. Turk Neurosurg. 2021;31(2):206\u2013210.", "ArticleIdList": ["33372254"]}, {"Citation": "Shaheen R., Anazi S., Ben-Omran T., Seidahmed M.Z., Caddle L.B., Palmer K., Ali R., Alshidi T., Hagos S., Goodwin L., Hashem M., Wakil S.M., Abouelhoda M., Colak D., Murray S.A., Alkuraya F.S. Mutations in SMG9, encoding an essential component of nonsense-mediated decay machinery, cause a multiple congenital anomaly syndrome in humans and mice. Am. J. Hum. Genet. 2016;98(4):643\u2013652.", "ArticleIdList": ["PMC4833216", "27018474"]}, {"Citation": "diener j.  2023. 2D Minimal Bounding Box.https://www.mathworks.com/matlabcentral/fileexchange/31126-2d-minimal-bounding-box Accessed 9/7/2023."}, {"Citation": "Westerfield M. M. Westerfield; 1995. The Zebrafish Book: A Guide for the Laboratory Use of Zebrafish (Danio Rerio)"}, {"Citation": "Str\u00e4hle U., Scholz S., Geisler R., Greiner P., Hollert H., Rastegar S., Schumacher A., Selderslaghs I., Weiss C., Witters H., Braunbeck T. Zebrafish embryos as an alternative to animal experiments\u2014a commentary on the definition of the onset of protected life stages in animal welfare regulation. Reprod. Toxicol. 2011;33:128\u2013132.", "ArticleIdList": ["21726626"]}, {"Citation": "Vanhaecke T., Papeleu P., Elaut G., Rogiers V. Trichostatin A - like hydroxamate histone deacetylase inhibitors as therapeutic agents: toxicological point of view. Curr. Med. Chem. 2004;11(12):1629\u20131643.", "ArticleIdList": ["15180568"]}, {"Citation": "Kimmel C.B., Ballard W.W., Kimmel S.R., Ullmann B., Schilling T.F. Stages of embryonic development of the zebrafish. Dev. Dynam. 1995;203(3):253\u2013310.", "ArticleIdList": ["8589427"]}, {"Citation": "Lv X., Qiu J., Hao T., Zhang H., Jiang H., Tan Y. HDAC inhibitor Trichostatin A suppresses adipogenesis in 3T3-L1 preadipocytes. Aging (Albany NY) 2021;13(13):17489\u201317498.", "ArticleIdList": ["PMC8312440", "34232916"]}, {"Citation": "Spiekermann K., Faber F., Voswinckel R., Hiddemann W. The protein tyrosine kinase inhibitor SU5614 inhibits VEGF-induced endothelial cell sprouting and induces growth arrest and apoptosis by inhibition of c-kit in AML cells. Exp. Hematol. 2002;30(7):767\u2013773.", "ArticleIdList": ["12135675"]}, {"Citation": "Thakur A., Faujdar C., Sharma R., Sharma S., Malik B., Nepali K., Liou J.P. Glioblastoma: current status, emerging targets, and recent advances. J. Med. Chem. 2022;65(13):8596\u20138685.", "ArticleIdList": ["PMC9297300", "35786935"]}, {"Citation": "Asklund T., Kvarnbrink S., Holmlund C., Wibom C., Bergenheim T., Henriksson R., Hedman H. Synergistic killing of glioblastoma stem-like cells by bortezomib and HDAC inhibitors. Anticancer Res. 2012;32(7):2407\u20132413.", "ArticleIdList": ["22753697"]}, {"Citation": "He Y.L., Yang H.Y., Huang P.Z., Feng W.J., Gao K. Cytotoxic cardenolides from Calotropis gigantea. Phytochemistry. 2021;192", "ArticleIdList": ["34563976"]}, {"Citation": "Choedon T., Mathan G., Arya S., Kumar V.L., Kumar V. Anticancer and cytotoxic properties of the latex of Calotropis procera in a transgenic mouse model of hepatocellular carcinoma. World J. Gastroenterol. 2006;12(16):2517\u20132522.", "ArticleIdList": ["PMC4087983", "16688796"]}, {"Citation": "Mathur R., Gupta S.K., Mathur S.R., Velpandian T. Anti-tumor studies with extracts of Calotropis procera (Ait.) R.Br. root employing Hep 2 cells and their possible mechanism of action. Indian J. Exp. Biol. 2009;47(5):343\u2013348.", "ArticleIdList": ["19579799"]}, {"Citation": "Joshi A.L., Roham P.H., Mhaske R., Jadhav M., Krishnadas K., Kharat A., Hardikar B., Kharat K.R. Calotropis procera extract induces apoptosis and cell cycle arrest at G2/M phase in human skin melanoma (SK-MEL-2) cells. Nat. Prod. Res. 2015;29(23):2261\u20132264.", "ArticleIdList": ["25623835"]}, {"Citation": "Soares de Oliveira J., Pereira Bezerra D., Teixeira de Freitas C.D., Delano Barreto Marinho Filho J., Odorico de Moraes M., Pessoa C., Costa-Lotufo L.V., Ramos M.V. In vitro cytotoxicity against different human cancer cell lines of laticifer proteins of Calotropis procera (Ait.) R. Br, Toxicol In Vitro. 2007;21(8):1563\u20131573.", "ArticleIdList": ["17604595"]}, {"Citation": "Bou Malhab L.J., Bajbouj K., Shehab N.G., Elayoty S.M., Sinoj J., Adra S., Taneera J., Saleh M.A., Abdel-Rahman W.M., Semreen M.H., Alzoubi K.H., Bustanji Y., El-Huneidi W., Abu-Gharbieh E. Potential anticancer properties of calotropis procera: an investigation on breast and colon cancer cells. Heliyon. 2023;9(6)", "ArticleIdList": ["PMC10272338", "37332907"]}, {"Citation": "Abu-Gharbieh E., Bajbouj K., Shehab N.G., Elayoty S.M., Abdel-Rahman W.M., Bustanji Y., Sinoj J., El-Huneidi W. Ethanolic extract of calotropis procera exhibits antitumor effects on human breast and colon cancer cells via cell cycle arrest. Faseb. J. 2022;36(S1)"}, {"Citation": "Saddiq A.A., Tag H.M., Doleib N.M., Salman A.S., Hagagy N. Antimicrobial, antigenotoxicity, and characterization of calotropis procera and its rhizosphere-inhabiting actinobacteria: in vitro and in vivo studies. Molecules. 2022;27(10)", "ArticleIdList": ["PMC9146570", "35630600"]}, {"Citation": "Kumar A., Kumar B., Kumar R., Kumar A., Singh M., Tiwari V., Trigunayat A., Paul P., Singh P. Acute and subacute toxicity study of ethanolic extract of Calotropis procera (Aiton) Dryand flower in Swiss albino mice. Phytomedicine. 2022;2(2)"}, {"Citation": "de Lima J.M., de Freitas F.J.C., Amorim R.N.L., C\u00e2mara A.C.L., Batista J.S., Soto-Blanco B. Clinical and pathological effects of Calotropis procera exposure in sheep and rats. Toxicon. 2011;57(1):183\u2013185.", "ArticleIdList": ["21087619"]}, {"Citation": "Fu Z.P., Chen X., Guan S.W., Yan Y.J., Lin H., Hua Z.C. Curcumin inhibits angiogenesis and improves defective hematopoiesis induced by tumor-derived VEGF in tumor model through modulating VEGF-VEGFR2 signaling pathway. Oncotarget. 2015;6(23):19469\u201319482.", "ArticleIdList": ["PMC4637299", "26254223"]}, {"Citation": "Mathur R., Gupta S.K., Mathur S.R., Velpandian T. Calotropis procera root extracts block VEGF-induced angiogenesis: quantitative analysis. Indian J. Physiol. Pharmacol. 2011;55(1):5\u201312.", "ArticleIdList": ["22315805"]}, {"Citation": "Scholar E. In: xPharm: the Comprehensive Pharmacology Reference. Enna S.J., Bylund D.B., editors. Elsevier; New York: 2007. Semaxinib; pp. 1\u20134."}, {"Citation": "Pastorino O., Gentile M.T., Mancini A., Del Gaudio N., Di Costanzo A., Bajetto A., Franco P., Altucci L., Florio T., Stoppelli M.P., Colucci-D'Amato L. Histone deacetylase inhibitors impair vasculogenic mimicry from glioblastoma cells. Cancers. 2019;11(6)", "ArticleIdList": ["PMC6627137", "31146471"]}, {"Citation": "Zhang D.F., Li X.G., Su L.J., Meng Q.L. Expression of activin A and follistatin in glioblastoma and their effects on U87 in vitro. J. Int. Med. Res. 2010;38(4):1343\u20131353.", "ArticleIdList": ["20926007"]}, {"Citation": "Ervolino De Oliveira C., Dourado M.R., Sawazaki-Calone \u00cd., Costa De Medeiros M., Rossa J\u00fanior C., De Karla Cervigne N., Esquiche Le\u00f3n J., Lambert D., Salo T., Graner E., Coletta R.D. Activin A triggers angiogenesis via regulation of VEGFA and its overexpression is associated with poor prognosis of oral squamous cell carcinoma. Int. J. Oncol. 2020;57(1):364\u2013376.", "ArticleIdList": ["32377747"]}, {"Citation": "Fisher K.L., Gorman C.M., Vehar G.A., O'Brien D.P., Lawn R.M. Cloning and expression of human tissue factor cDNA. Thromb. Res. 1987;48(1):89\u201399.", "ArticleIdList": ["3424286"]}, {"Citation": "de Bono J.S., Harris J.R., Burm S.M., Vanderstichele A., Houtkamp M.A., Aarass S., Riisnaes R., Figueiredo I., Nava Rodrigues D., Christova R., Olbrecht S., Niessen H.W.M., Ruuls S.R., Schuurhuis D.H., Lammerts van Bueren J.J., Breij E.C.W., Vergote I. Systematic study of tissue factor expression in solid tumors. Cancer Reports. 2023;6(2):e1699.", "ArticleIdList": ["PMC9940005", "36806722"]}, {"Citation": "Bluff J.E., Brown N.J., Reed M.W., Staton C.A. Tissue factor, angiogenesis and tumour progression. Breast Cancer Res. 2008;10(2):204.", "ArticleIdList": ["PMC2397518", "18373885"]}, {"Citation": "Li X., Cao D., Zheng X., Wang G., Liu M. Tissue factor as a new target for tumor therapy\u2014killing two birds with one stone: a narrative review. Ann. Transl. Med. 2022;10(22):1250.", "ArticleIdList": ["PMC9761121", "36544632"]}, {"Citation": "Lee P., Murphy B., Miller R., Menon V., Banik N.L., Giglio P., Lindhorst S.M., Varma A.K., Vandergrift W.A., 3rd, Patel S.J., Das A. Mechanisms and clinical significance of histone deacetylase inhibitors: epigenetic glioblastoma therapy. Anticancer Res. 2015;35(2):615\u2013625.", "ArticleIdList": ["PMC6052863", "25667438"]}, {"Citation": "Merarchi M., Sethi G., Shanmugam M.K., Fan L., Arfuso F., Ahn K.S. Role of natural products in modulating histone deacetylases in cancer. Molecules. 2019;24(6)", "ArticleIdList": ["PMC6471757", "30884859"]}, {"Citation": "Nepali K., Liou J.-P. Recent developments in epigenetic cancer therapeutics: clinical advancement and emerging trends. J. Biomed. Sci. 2021;28(1):27.", "ArticleIdList": ["PMC8040241", "33840388"]}, {"Citation": "Seto E., Yoshida M. Erasers of histone acetylation: the histone deacetylase enzymes. Cold Spring Harbor Perspect. Biol. 2014;6(4)", "ArticleIdList": ["PMC3970420", "24691964"]}, {"Citation": "Li J., Yan X., Liang C., Chen H., Liu M., Wu Z., Zheng J., Dang J., La X., Liu Q. Comprehensive analysis of the differential expression and prognostic value of histone deacetylases in glioma. Front. Cell Dev. Biol. 2022;10", "ArticleIdList": ["PMC8961059", "35359455"]}, {"Citation": "Li J., Yan X., Liang C., Chen H., Liu M., Wu Z., Zheng J., Dang J., La X., Liu Q. Comprehensive analysis of the differential expression and prognostic value of histone deacetylases in glioma. Front. Cell Dev. Biol. 2022;10", "ArticleIdList": ["PMC8961059", "35359455"]}]}], "History": [{"Year": "2023", "Month": "8", "Day": "17"}, {"Year": "2023", "Month": "12", "Day": "16"}, {"Year": "2024", "Month": "1", "Day": "8"}, {"Year": "2024", "Month": "2", "Day": "2", "Hour": "6", "Minute": "43"}, {"Year": "2024", "Month": "2", "Day": "2", "Hour": "6", "Minute": "42"}, {"Year": "2024", "Month": "2", "Day": "2", "Hour": "4", "Minute": "13"}, {"Year": "2024", "Month": "1", "Day": "12"}], "PublicationStatus": "epublish", "ArticleIdList": ["38304784", "PMC10831610", "10.1016/j.heliyon.2024.e24406", "S2405-8440(24)00437-7"]}}]}